Cath, over at VWXYNot, has a post up describing the changes being proposed by CIHR (the Canadian NIH) to revamp the review process there and alter their funding structure. These changes are being fueled by some of the same pressures that influenced NSF Bio to undergo recent changes.
As I commented on the post, I’m sure this will play out like all of these transitions do – initial screaming by the constituency, followed by screams returning to baseline levels in a year or two. The issue is that funding agencies have to do something to solve some major problems. They are not always going to get it right, but they have the money, so they make the rules. We can complain (and probably will), but it is what it is. Adapt or fall behind.